TWM
FBT icon

TriaGen Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

TriaGen Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
10,445
+4,499
+76% +$969K 0.65% 33
2026
Q1 		$1.19M Buy
+5,946
New +$1.23M 0.33% 67

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

TriaGen Wealth Management's FBT Position: Q2 2026 in Review

TriaGen Wealth Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 76% in Q2 2026, buying an estimated $969K and bringing the position to 10,445 shares worth $2.59M. The position accounts for 0.65% of the portfolio, ranked #33.

TriaGen Wealth Management first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • TriaGen Wealth Management held 10,445 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.59M as of Q2 2026.
  • TriaGen Wealth Management bought 4,499 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $969K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.65% of TriaGen Wealth Management's portfolio in Q2 2026, its #33 holding.
  • TriaGen Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.